🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 17 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/09/2000 48,66 49,59 47,72 48,19 -2,37% 3,85% 22.308
20/09/2000 48,89 50,53 47,26 49,36 +3,43% 6,70% 47.743
19/09/2000 46,32 48,66 45,85 47,72 +2,00% 6,06% 70.425
18/09/2000 48,31 49,59 44,21 46,79 -4,76% 11,14% 72.856
15/09/2000 47,26 49,59 47,26 49,13 +0,48% 4,95% 50.575
14/09/2000 49,13 50,53 48,66 48,89 -1,42% 3,81% 83.383
13/09/2000 49,83 50,06 48,42 49,59 -1,85% 3,29% 50.949
12/09/2000 47,96 51,47 47,96 50,53 +6,40% 7,32% 48.330
11/09/2000 48,66 51,93 47,02 47,49 -4,69% 10,10% 74.379
08/09/2000 48,89 50,53 47,72 49,83 +0,47% 5,74% 43.041
07/09/2000 47,72 49,59 47,49 49,59 +3,92% 4,41% 45.873
06/09/2000 49,13 49,59 47,72 47,72 -2,39% 3,81% 38.712
05/09/2000 50,76 51,93 48,66 48,89 -2,34% 6,45% 53.701
01/09/2000 52,17 52,40 47,96 50,06 +2,88% 8,52% 92.894
31/08/2000 48,42 49,36 46,32 48,66 +0,97% 6,28% 68.689
30/08/2000 46,79 48,19 46,32 48,19 +4,04% 4,00% 46.487
29/08/2000 48,66 48,66 45,85 46,32 -2,46% 5,77% 69.837
28/08/2000 44,45 48,19 43,75 47,49 +12,78% 10,00% 149.560
25/08/2000 41,41 43,75 40,94 42,11 +2,27% 6,78% 152.499
24/08/2000 39,30 42,11 38,37 41,17 +7,32% 9,52% 172.750
23/08/2000 38,60 39,54 37,66 38,37 +1,23% 4,85% 64.815
22/08/2000 39,89 40,00 37,66 37,90 -2,41% 5,86% 61.609
21/08/2000 38,13 40,00 37,43 38,83 +3,75% 6,75% 104.008
18/08/2000 39,77 40,47 37,43 37,43 -5,33% 7,65% 109.271
17/08/2000 38,60 40,70 38,60 39,54 +0,60% 5,45% 99.573
16/08/2000 41,17 41,64 39,07 39,30 -1,75% 6,25% 79.910
15/08/2000 43,98 44,21 39,30 40,00 -5,00% 11,17% 102.913
14/08/2000 42,11 42,58 40,47 42,11 +1,69% 5,00% 43.147
11/08/2000 41,52 41,87 39,30 41,41 -0,56% 6,20% 27.064
10/08/2000 40,94 41,87 40,24 41,64 +2,30% 4,00% 46.166